Status:
UNKNOWN
Taste Receptors Regulation in CF Patients
Lead Sponsor:
Medical University of Lodz
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
6+ years
Phase:
NA
Brief Summary
The project is intended to be realised in two phases. In the first stage, a case control study will be performed. In the second phase, double-blind, placebo controlled cross-over study will be conduct...
Detailed Description
Three visits have been planned during the entire study. During the first visit, all patients included in the study will have the following procedures: questionnaire tests, lung function tests, taste p...
Eligibility Criteria
Inclusion
- ulmonary manifestations of cystic fibrosis
Exclusion
- first positive result of inoculation from the airways, which according to the standard is associated with the need for antibiotic therapy
- contraindication to a biopsy of the nasal mucosa
- exacerbation requiring antibiotics
- diabetes, exposure to tobacco smoke
- other chronic diseases and clinical conditions which, according to the researcher, may influence the assessed parameters and the course of the study.
- Temporary exclusion criteria
- \- acute respiratory infection within 2 weeks from 1, 2 and 3 visits of the study.
Key Trial Info
Start Date :
July 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04058340
Start Date
July 30 2019
End Date
December 30 2019
Last Update
August 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland
Lodz, Poland, 90-153